Toshiro Shibano

1.2k total citations
54 papers, 1.0k citations indexed

About

Toshiro Shibano is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Toshiro Shibano has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 22 papers in Hematology and 15 papers in Molecular Biology. Recurrent topics in Toshiro Shibano's work include Blood Coagulation and Thrombosis Mechanisms (16 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Venous Thromboembolism Diagnosis and Management (12 papers). Toshiro Shibano is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (16 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Venous Thromboembolism Diagnosis and Management (12 papers). Toshiro Shibano collaborates with scholars based in Japan, United States and Germany. Toshiro Shibano's co-authors include Y Morishima, Taketoshi Furugohri, Yuko Honda, Nobutoshi Sugiyama, K. Isobe, Takayasu Nagahara, Mitsuru Murata, Yasuo Ikeda, Hiroaki Ishihara and Toshihiro Uchida and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

Toshiro Shibano

53 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiro Shibano Japan 17 541 304 274 188 146 54 1.0k
H. Patscheke Germany 18 271 0.5× 515 1.7× 142 0.5× 196 1.0× 90 0.6× 57 1.2k
Benjamin E. Tourdot United States 15 213 0.4× 261 0.9× 105 0.4× 213 1.1× 94 0.6× 24 822
Jean‐Louis David Belgium 19 481 0.9× 189 0.6× 172 0.6× 153 0.8× 36 0.2× 41 1.0k
Gertie Gorter Netherlands 23 415 0.8× 437 1.4× 55 0.2× 412 2.2× 151 1.0× 51 1.3k
Ross Bentley United States 19 369 0.7× 112 0.4× 83 0.3× 375 2.0× 44 0.3× 33 951
P. Schanzenbächer Germany 12 460 0.9× 144 0.5× 80 0.3× 177 0.9× 30 0.2× 30 782
D J Rader United States 17 236 0.4× 351 1.2× 86 0.3× 286 1.5× 57 0.4× 21 1.5k
Wendy Tomlinson United Kingdom 11 377 0.7× 131 0.4× 124 0.5× 210 1.1× 27 0.2× 14 757
Ugo Cavallari Italy 16 428 0.8× 72 0.2× 113 0.4× 191 1.0× 67 0.5× 30 967
David C. B. Mills United States 11 211 0.4× 276 0.9× 34 0.1× 136 0.7× 67 0.5× 15 676

Countries citing papers authored by Toshiro Shibano

Since Specialization
Citations

This map shows the geographic impact of Toshiro Shibano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiro Shibano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiro Shibano more than expected).

Fields of papers citing papers by Toshiro Shibano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiro Shibano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiro Shibano. The network helps show where Toshiro Shibano may publish in the future.

Co-authorship network of co-authors of Toshiro Shibano

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiro Shibano. A scholar is included among the top collaborators of Toshiro Shibano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiro Shibano. Toshiro Shibano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shirasaki, Yasufumi, Y Morishima, & Toshiro Shibano. (2013). Comparison of the effect of edoxaban, a direct factor Xa inhibitor, with a direct thrombin inhibitor, melagatran, and heparin on intracerebral hemorrhage induced by collagenase in rats. Thrombosis Research. 133(4). 622–628. 5 indexed citations
2.
Furugohri, Taketoshi, et al.. (2012). Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats. European Journal of Pharmacology. 686(1-3). 74–80. 9 indexed citations
3.
Matsubara, Yumiko, et al.. (2011). GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro. Platelets. 22(3). 196–203. 13 indexed citations
4.
Furugohri, Taketoshi, K. Isobe, Yuko Honda, et al.. (2008). DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. Journal of Thrombosis and Haemostasis. 6(9). 1542–1549. 246 indexed citations
5.
Takahashi, Shinichi, Toshihiro Uchida, Hiroaki Ishihara, et al.. (2007). Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms. Thrombosis Research. 121(4). 509–517. 23 indexed citations
6.
Matsubara, Yumiko, Mitsuru Murata, Yosuke Okamura, et al.. (2005). Platelet glycoprotein Ib alpha polymorphisms affect the interaction with von Willebrand factor under flow conditions. British Journal of Haematology. 128(4). 533–539. 9 indexed citations
7.
8.
9.
10.
Murata, Mitsuru, Yumiko Matsubara, Toshihiro Uchida, et al.. (2003). Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets. Biochemical and Biophysical Research Communications. 313(1). 212–216. 84 indexed citations
11.
Adamson, Philip B., Emilio Vanoli, Toshiro Shibano, Robert D. Foreman, & Peter J. Schwartz. (2003). Combined Sodium and Calcium Channel Blockade in Prevention of Lethal Arrhythmias. Journal of Cardiovascular Pharmacology. 41(5). 665–670. 2 indexed citations
12.
Moriyama, Sachiko, et al.. (2002). Rational Design and Evaluation of New Lead Compound Structures for Selective βARK1 Inhibitors. Journal of Medicinal Chemistry. 45(11). 2150–2159. 36 indexed citations
13.
Kuniyasu, Akihiko, et al.. (1998). Photochemical Identification of Transmembrane Segment IVS6 as the Binding Region of Semotiadil, a New Modulator for the L-type Voltage-dependent Ca2+ Channel. Journal of Biological Chemistry. 273(8). 4635–4641. 11 indexed citations
14.
Shibano, Toshiro, et al.. (1996). Substrate recognition mechanism of human beta-adrenergic receptor kinase 1 based on a three-dimensional model structure.. PubMed. 14(2). 145–55. 1 indexed citations
15.
Chiba, Kiyoshi, et al.. (1995). Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model. British Journal of Pharmacology. 116(1). 1668–1672. 24 indexed citations
16.
Shibano, Toshiro, et al.. (1993). Pharmacological profile of a new 5-hydroxytryptamine2 receptor antagonist, DV-7028.. PubMed. 319. 114–28. 10 indexed citations
17.
Tanaka, Takashi, Y Morishima, Kenji Watanabe, et al.. (1993). Combined effect of the 5-HT2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs. Cardiovascular Research. 27(7). 1374–1379. 7 indexed citations
18.
Shibano, Toshiro, Juan Codina, Lutz Birnbaumer, & Paul M. Vanhoutte. (1992). Guanosine 5′-O-(3-thiotriphosphate) causes endothelium-dependent, pertussis toxin-sensitive relaxations in porcine coronary arteries. Biochemical and Biophysical Research Communications. 189(1). 324–329. 13 indexed citations
19.
Watanabe, Yoshifumi, et al.. (1990). Syntheses of monocyclic and bicyclic 2,4(1H,3H)-pyrimidinediones and their serotonin 2 antagonist activities.. Chemical and Pharmaceutical Bulletin. 38(10). 2726–2732. 6 indexed citations
20.
Shibano, Toshiro, et al.. (1986). Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on cardiac anaphylaxis in guinea pig isolated heart. The Japanese Journal of Pharmacology. 40. 257–257. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Patscheke Breakdown of academic impact, for papers by Benjamin E. Tourdot Breakdown of academic impact, for papers by Jean‐Louis David Breakdown of academic impact, for papers by Gertie Gorter Breakdown of academic impact, for papers by Ross Bentley Breakdown of academic impact, for papers by P. Schanzenbächer Breakdown of academic impact, for papers by D J Rader Breakdown of academic impact, for papers by Wendy Tomlinson Breakdown of academic impact, for papers by Ugo Cavallari Breakdown of academic impact, for papers by David C. B. Mills
Rankless by CCL
2026